Yoichiro Sato

Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

Ryoichi Fujii, Yorihisa Imanishi, Katsushi Shibata et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 59 citations · Full text

Medicine, Oncology, Pharmacology +16

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma

Noboru Habu, Yorihisa Imanishi, Kaori Kameyama et al. · BMC Cancer · 2015 · 39 citations · Full text

Medicine, Cell Biology, Oncology +17

Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer

Yorihisa Imanishi, Hiroyuki Ozawa, Koji Sakamoto et al. · BMC Cancer · 2017 · 28 citations · Full text

Medicine, Oncology, Surgery +17

Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.

Yoshihiro Watanabe, Yorihisa Imanishi, Hiroyuki Ozawa et al. · PubMed · 2020 · 23 citations · Full text

Medicine, Cancer Biology, Cell Biology +16

VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner.

Seiji Shigetomi, Yorihisa Imanishi, Katsushi Shibata et al. · PubMed · 2018 · 21 citations · Full text

Medicine, Cancer Biology, Oncology +17